Q1 EPS Forecast for USANA Health Sciences Boosted by Analyst

USANA Health Sciences, Inc. (NYSE:USNA) – Research analysts at Sidoti Csr lifted their Q1 2026 earnings per share (EPS) estimates for USANA Health Sciences in a report released on Tuesday, December 24th. Sidoti Csr analyst A. Lebiedzinski now expects that the company will post earnings of $0.91 per share for the quarter, up from their prior estimate of $0.82. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2026 earnings at $0.88 EPS and Q3 2026 earnings at $0.91 EPS.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. The firm had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the prior year, the company earned $0.59 EPS.

Other analysts also recently issued reports about the company. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research report on Thursday, December 19th. DA Davidson upgraded USANA Health Sciences to a “hold” rating in a report on Friday, December 20th.

USANA Health Sciences Price Performance

Shares of USNA opened at $35.94 on Wednesday. USANA Health Sciences has a 1-year low of $31.44 and a 1-year high of $54.81. The stock has a market cap of $685.02 million, a price-to-earnings ratio of 12.70, a price-to-earnings-growth ratio of 1.25 and a beta of 0.89. The firm has a 50 day simple moving average of $37.88 and a 200-day simple moving average of $40.01.

Insider Buying and Selling at USANA Health Sciences

In related news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by corporate insiders.

Institutional Trading of USANA Health Sciences

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Pzena Investment Management LLC lifted its holdings in USANA Health Sciences by 24.4% in the second quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after acquiring an additional 191,289 shares during the last quarter. Pacer Advisors Inc. grew its position in USANA Health Sciences by 16.5% in the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after buying an additional 76,904 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of USANA Health Sciences by 14,068.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after acquiring an additional 38,547 shares during the period. Deerfield Management Company L.P. Series C raised its position in USANA Health Sciences by 297.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after acquiring an additional 22,251 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new position in shares of USANA Health Sciences in the second quarter valued at $890,000. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.